Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure
QUANTICO-RETRO
1 other identifier
observational
1,000
1 country
2
Brief Summary
Automated quantification of the pulmonary volume impaired during acute respiratory failure could be helpful to assess patient severity during COVID-19 infection or perioperative medicine, for example. This study aim at assessing the correlation between the amount of radiologic pulmonary alteration and the clinical severity in two clinical situation :
- 1.SARS-CoV-2 infections
- 2.Postoperative hypoxemic acute respiratory failure
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2020
CompletedFirst Posted
Study publicly available on registry
September 1, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedApril 18, 2023
April 1, 2023
3.5 years
August 26, 2020
April 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between altered pulmonary volume and ordinal severity scale
2 days after CT scan
Secondary Outcomes (1)
Correlation between altered pulmonary volume and ordinal severity scale
7 days after CT scan
Study Arms (2)
Patients with SARS-CoV-2 infection
Patients with Postoperative hypoxemic respiratory failure
Interventions
Automated measurement
Eligibility Criteria
Hospitalized patients that underwent a thoracic CT-scan
You may qualify if:
- patient with insurance covering
- patient admitted to the participating hospitals for SARS-CoV-2 infection or postoperative acute hypoxemic respiratory failure between 01/01/2019 and 05/11/2020
You may not qualify if:
- \- patient transferred to another hospital than the participating center during the 7 days following the CT scan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Strasbourg, Francelead
- VISIBLE PATIENT, E-MEDIAcollaborator
Study Sites (2)
HÔPITAUX UNIVERSITAIRES DE STRASBOURG, Hôpital de Hautepierre, Service de Réanimation Médicale
Strasbourg, 67098, France
Hôpitaux Universitaires de Nancy Service d'anesthésie réanimation Hôpital de Brabois
Vandœuvre-lès-Nancy, 54500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2020
First Posted
September 1, 2020
Study Start
September 1, 2020
Primary Completion
March 1, 2024
Study Completion
March 1, 2024
Last Updated
April 18, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share